透析前低钠血症与终末期肾病患者透析后不良结局的关联
BACKGROUND: Hyponatremia is one of the most common electrolyte disturbances in advanced chronic kidney disease (CKD) and end-stage kidney disease (ESKD) patients, and has been shown to be associated with higher mortality risk.…
要点
- 透析前血钠<130 mEq/L与透析后全因死亡风险增加54%独立相关。
- 低钠血症与心血管死亡、感染相关死亡及住院率也呈相似关联。
- 提示需关注透析前低钠血症的管理以改善患者结局。
核心结论
- 透析前低钠血症与透析后全因死亡、心血管死亡、感染相关死亡及住院率升高相关。
研究设计与样本
- 评估透析前3个月平均血清钠与全因死亡等结局的校正关联。
主要发现
- 队列平均血清钠139±3 mEq/L,平均年龄67±11岁,98%为男性,28%为非裔美国人。
- 与参考组135至<144 mEq/L相比,血钠<130 mEq/L组全因死亡风险高54%(HR 1.54,95%CI 1.34-1.76)。
- 心血管死亡、感染相关死亡及住院率的关联与全因死亡相似。
临床怎么用
- 对透析前低钠血症患者应加强监测与管理,可能有助于改善透析后结局。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hyponatremia is one of the most common electrolyte disturbances in advanced chronic kidney disease (CKD) and end-stage kidney disease (ESKD) patients, and has been shown to be associated with higher mortality risk. However, the relationship between hyponatremia during late-stage CKD and the risk of poor outcomes after ESKD transition is unknown. METHODS: We conducted a retrospective cohort study including 32 257 US veterans transitioning to ESKD from 1 October 2007 to 30 March 2015. We evaluated adjusted associations between the 3-month averaged pre-transition to ESKD serum sodium and all-cause mortality. Secondary outcomes included cardiovascular (CV) mortality, infection-related mortalities and hospitalization rate. RESULTS: Cohort mean ± standard deviation serum sodium was 139 ± 3 mEq/L, mean age was 67 ± 11 years, 98% were male and 28% were African American. Over a median (interquartile range) follow-up of 702 days (296, 1301) there were 17 162 deaths. Compared with the reference of 135 to <144 mEq/L, the lowest serum sodium group (<130 mEq/L) had a 54% higher all-cause mortality risk [hazard ratio 1.54 (95% confidence interval 1.34-1.76)] in the fully adjusted model. Associations were similar for CV and infection-related mortality, and hospitalization outcomes. CONCLUSIONS: Hyponatremia prior to ESKD transition is associated with higher risk of all-cause, CV and infection-related mortalities, and hospitalization rates after ESKD transition. Future studies evaluating management of pre-ESKD hyponatremia may be indicated to improve patient outcomes for those transitioning to ESKD.
引用
- Marroquin MV, Sy J, Kleine CE, et al. Association of pre-ESKD hyponatremia with post-ESKD outcomes among incident ESKD patients. Nephrol Dial Transplant. 2022. PMID: 34390572. doi:10.1093/ndt/gfab203
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。